Sonoma Pharmaceuticals, Inc. , develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally.
Sonoma Pharmaceuticals stock last closed at $3.68, up 0% from the previous day, and has decreased 52.77% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.16 percentage points. Sonoma Pharmaceuticals stock is currently +110.29% from its 52-week low of $1.75, and -59.11% from its 52-week high of $9.00.
There are currently 1.64M SNOA shares outstanding. The market value of SNOA is $6.05M. In the last 24 hours, 91,000 SNOA shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy SNOA shares.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you need to fill out some personal information so you are able to invest in SNOA stock today.
Now that you have finished signing up on apps for stock market, your next step is to transfer the money for your investment:
Check out the tutorial below for more details depositing funds into your new investment account.
After you have selected the best place to buy Sonoma Pharmaceuticals stock, it's critical to evaluate their stock before you buy, so you can understand the risk and upside.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SNOA's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge SNOA's true value.
Using relative valuations metrics:
You can do additional valuation analysis on SNOA's stock here.
You can dive deeper into what analysts are forecasting on the Sonoma Pharmaceuticals stock forecast page.
Last year, SNOA revenue was $14.29M. In the past five year, SNOA's revenue has gone up by -4.44% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 9.62%.
Dive into SNOA's earnings and revenue performance here.
In the past 12 months, insiders at SNOA have not bought or sold any shares.
Research more about who owns SNOA shares here.
No, Sonoma Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two main options:
Click the Open button and your broker will place your order.
If you need additional help with investing in stocks on eToro, watch the helpful video below:
Now that you own some SNOA shares, you'll want to keep up with your new stock purchase.
Start a watchlist to monitor your SNOA stock.
To summarize, here are the 6 steps to buy Sonoma Pharmaceuticals stock:
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Sonoma Pharmaceuticals, hit the button below to create your watchlist.